These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28299666)

  • 1. RUNX3 and p53: How Two Tumor Suppressors Cooperate Against Oncogenic Ras?
    Lee JW; van Wijnen A; Bae SC
    Adv Exp Med Biol; 2017; 962():321-332. PubMed ID: 28299666
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Ito K; Otani S; Date Y
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190031
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Lee YS; Lee JY; Song SH; Kim DM; Lee JW; Chi XZ; Ito Y; Bae SC
    Mol Cells; 2020 Oct; 43(10):889-897. PubMed ID: 33115981
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional relationship between p53 and RUNX proteins.
    Bae SC; Kolinjivadi AM; Ito Y
    J Mol Cell Biol; 2019 Mar; 11(3):224-230. PubMed ID: 30535344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RUNX Family of Proteins, DNA Repair, and Cancer.
    Krishnan V
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Runx3 Restoration Regresses K-Ras-Activated Mouse Lung Cancers and Inhibits Recurrence.
    Lee JY; Lee JW; Park TG; Han SH; Yoo SY; Jung KM; Kim DM; Lee OJ; Kim D; Chi XZ; Kim EG; Lee YS; Bae SC
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Runt-related transcription factor RUNX3 is a target of MDM2-mediated ubiquitination.
    Chi XZ; Kim J; Lee YH; Lee JW; Lee KS; Wee H; Kim WJ; Park WY; Oh BC; Stein GS; Ito Y; van Wijnen AJ; Bae SC
    Cancer Res; 2009 Oct; 69(20):8111-9. PubMed ID: 19808967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53.
    Yamada C; Ozaki T; Ando K; Suenaga Y; Inoue K; Ito Y; Okoshi R; Kageyama H; Kimura H; Miyazaki M; Nakagawara A
    J Biol Chem; 2010 May; 285(22):16693-703. PubMed ID: 20353948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Regulatory Role for RUNX1, RUNX3 in the Maintenance of Genomic Integrity.
    Krishnan V; Ito Y
    Adv Exp Med Biol; 2017; 962():491-510. PubMed ID: 28299675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
    Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y
    Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic RUNX3: A Link between p53 Deficiency and MYC Dysregulation.
    Date Y; Ito K
    Mol Cells; 2020 Feb; 43(2):176-181. PubMed ID: 31991537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.
    Spender LC; Whiteman HJ; Karstegl CE; Farrell PJ
    Oncogene; 2005 Mar; 24(11):1873-81. PubMed ID: 15688019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Runx genes as dominant oncogenes.
    Cameron ER; Blyth K; Hanlon L; Kilbey A; Mackay N; Stewart M; Terry A; Vaillant F; Wotton S; Neil JC
    Blood Cells Mol Dis; 2003; 30(2):194-200. PubMed ID: 12732183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic potential of the RUNX gene family: 'overview'.
    Ito Y
    Oncogene; 2004 May; 23(24):4198-208. PubMed ID: 15156173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Runx genes: lineage-specific oncogenes and tumor suppressors.
    Cameron ER; Neil JC
    Oncogene; 2004 May; 23(24):4308-14. PubMed ID: 15156187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Runx3 is required for oncogenic Myc upregulation in p53-deficient osteosarcoma.
    Otani S; Date Y; Ueno T; Ito T; Kajikawa S; Omori K; Taniuchi I; Umeda M; Komori T; Toguchida J; Ito K
    Oncogene; 2022 Jan; 41(5):683-691. PubMed ID: 34803166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor activity of RUNX3.
    Bae SC; Choi JK
    Oncogene; 2004 May; 23(24):4336-40. PubMed ID: 15156190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RUNX Genes as Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models.
    Neil JC; Gilroy K; Borland G; Hay J; Terry A; Kilbey A
    Adv Exp Med Biol; 2017; 962():247-264. PubMed ID: 28299662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RUNX family: Regulation and diversification of roles through interacting proteins.
    Chuang LS; Ito K; Ito Y
    Int J Cancer; 2013 Mar; 132(6):1260-71. PubMed ID: 23180629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Runx3 at the interface of immunity, inflammation and cancer.
    Lotem J; Levanon D; Negreanu V; Bauer O; Hantisteanu S; Dicken J; Groner Y
    Biochim Biophys Acta; 2015 Apr; 1855(2):131-43. PubMed ID: 25641675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.